Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint InhibitorsClaire Gallois, Matteo Landi, Julien Taieb, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2018
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferaseSarit Schwartz, Chris Szeto, Yuan Tian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance TherapyFederica Morano, Salvatore Corallo, Sara Lonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal CancerPaolo Manca, Salvatore Corallo, Adele Busico, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Cancers|December 11, 2019
EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation CohortArsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi, et al.
International Journal of Cancer|April 10, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasisAndreas Schlicker, Architha Ellappalayam, Ines J Beumer, et al.
Clinical Lung Cancer|August 10, 2022
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung CancerGiulia Galli, Paola Antonia Corsetto, Claudia Proto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2019
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal CancerFilippo Pietrantonio, Riccardo Lobefaro, Maria Antista, et al.
Tumori|June 12, 2020
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-SMaria Di Bartolomeo, Alessandra Raimondi, Fabiola Cecchi, et al.
Pageof 7